agilon health, inc. (AGL) represents an intriguing prospect within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Westerville, Ohio, the company focuses on providing healthcare services for seniors via primary care physicians across the United States. Its unique approach involves a platform that manages the total healthcare needs of patients through a subscription-like per-member per-month model, catering to an aging population with growing medical needs.
As of the latest trading data, agilon health’s stock is priced at 0.6941 USD, experiencing a slight uptick of 0.06% with a price change of 0.04 USD. Investors might find the 52-week range particularly telling, as it spans from a low of 0.51 USD to a high of 5.68 USD, indicating significant volatility yet also potential for substantial recovery.
The company’s market capitalization stands at $287.76 million, a reflection of its current valuation in the market. However, the financial metrics present a mixed bag. The forward P/E ratio is -1.83, and the company does not currently show a trailing P/E ratio or PEG ratio, highlighting challenges in profitability and growth valuation. Additionally, key metrics such as Price/Book and Price/Sales are not available, suggesting caution for investors seeking traditional valuation metrics.
Performance metrics also paint a challenging picture. With revenue growth at -1.10% and an EPS of -0.78, agilon health is navigating through hurdles in achieving profitability. The Return on Equity at -73.31% is notably concerning, alongside a negative free cash flow of -$23,255,124, suggesting liquidity constraints and potential operational inefficiencies.
Dividend investors might be disappointed as agilon health does not offer a dividend yield, and the payout ratio stands at 0.00%. This lack of dividends may steer income-focused investors toward other opportunities.
Analyst sentiment is cautious with 2 buy ratings, 14 hold ratings, and 2 sell ratings. The target price range is between 0.25 USD and 2.00 USD, with an average target price of 0.97 USD. This indicates a potential upside of 39.03% from the current price, which could attract risk-tolerant investors willing to bet on a turnaround.
From a technical standpoint, agilon health is trading below its 50-day moving average of 0.81 USD and significantly below the 200-day moving average of 2.18 USD. The Relative Strength Index (RSI) at 35.90 suggests that the stock is nearing oversold territory, which might present a buying opportunity for technical traders. Meanwhile, the MACD of -0.03 against the signal line of -0.06 indicates bearish momentum.
Investors considering agilon health should weigh the high volatility and current financial challenges against the potential for significant upside, especially if the company can capitalize on its unique healthcare platform. As always, a careful assessment of risk tolerance and investment horizon is crucial when evaluating such opportunities in the healthcare sector.
